Lipocine Inc (LPCN): Lipocine Announces Positive LPCN 2401 Cl...

Next 10 Prev Next

Send PM Follow Ignore

Followers	112
Posts	17606
Boards Moderated	0
Alias Born	06/24/2014

Awl416

Re: None

Thursday, 04/11/2024 7:08:13 AM

Thursday, April 11, 2024 7:08:13 AM

Lipocine Announces Positive LPCN 2401 Clinical Results Showing Improved Body Composition in Participants with Obesity

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent LPCN News

Form 8-K - Current report • Edgar (US Regulatory) • 05/26/2026 09:08:04 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/19/2026 01:00:16 PM
Lipocine Announces LPCN 1154 Phase 3 Data Accepted for Oral Presentation at 2026 ASCP Annual Meeting • PR Newswire (US) • 05/19/2026 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/18/2026 01:00:24 PM
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 05/15/2026 09:00:59 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 08:09:00 PM
Lipocine Announces Financial Results for the First Quarter Ended March 31, 2026 • PR Newswire (US) • 05/07/2026 08:05:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 01:05:14 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2026 01:00:59 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/21/2026 09:12:48 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/21/2026 09:01:02 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/21/2026 08:05:27 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/07/2026 10:27:25 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/06/2026 11:01:22 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/06/2026 10:33:10 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 09:05:58 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 01:40:13 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 01:35:13 PM
Lipocine Reports Topline Safety and Efficacy Results for LPCN 1154 in Patients with Postpartum Depression • PR Newswire (US) • 04/02/2026 12:00:00 PM
Lipocine Announces Financial Results for the Full Year Ended December 31, 2025 • PR Newswire (US) • 03/10/2026 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/10/2026 10:13:03 AM
Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2026 09:05:52 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/26/2026 10:33:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/18/2026 02:37:58 PM

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Detailed Quote

Recent LPCN News

More LPCN News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent LPCN News

Go Ad-Free